Immune Checkpoint Inhibitors in Endometrial Cancer: The New Paradigm of Treatment for Advanced and Recurrent Disease
Endometrial cancer is one of the most prevalent malignancies in women and the prognosis of metastatic and recurrent disease is dismal, with limited treatment options. Molecular classification based on data from the Cancer Genome Atlas (TCGA) project has markedly improved our understanding of the bio...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
THE HEALTHBOOK COMPANY LTD.
2023-12-01
|
| Series: | healthbook TIMES. Oncology Hematology |
| Online Access: | https://doi.org/10.36000/HBT.OH.2023.18.126 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|